Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Associated factors for COVID-19 mortality among children and adolescents in Rio de Janeiro state, 2020-2023.

Created on 20 Nov 2026

Authors

Lívia Esteves, Carlos Eduardo Raymundo, Roberto de Andrade Medronho

Published in

BMC pediatrics. Volume 26. Issue 1. Jul 31, 2026. Epub Jul 31, 2026.

Abstract

Children and adolescents with COVID-19 typically present milder symptoms of the infection, with fatal outcomes being rare. This study aimed to analyze the main associated factors for mortality in this population group.
A cross-sectional study was performed to analyze reported COVID-19 cases among individuals under 18 years old in Rio de Janeiro state, Brazil, from March 2021 to September 2023. Pearson's chi-square test was used for categorical variables, and the Wilcoxon test for numerical variables. The significance level was set at 5%. Logistic regression analysis was performed to identify factors associated with COVID-19 mortality in individuals under 18.
Infants under 1 year old had a higher mortality chance (OR = 4.70; 95% CI: 2.45-9.60) compared to adolescents aged 15-17 years. Non-white individuals had a lower mortality chance compared to white individuals (OR = 0.64; 95% CI: 0.41-0.99). The presence of fever (OR = 1.83; 95% CI: 1.17-2.89), dyspnea (OR = 11.83; 95% CI: 7.50-18.74), and oxygen saturation below 95% (OR = 11.97; 95% CI: 3.78-33.19) was associated with a higher mortality chance. Patients with heart disease (OR = 7.74; 95% CI: 3.89-14.58) and immunodeficiency/immunosuppression (OR = 17.16; 95% CI: 8.58-32.14) had a higher mortality chance. Infection during the predominance of variants B1_wild (OR = 3.44; CI 1.75-6.81), Gamma (OR = 3.93; CI 2.13-7.44), and Delta (OR = 2.27; CI 1.02-4.84) was associated with a higher mortality chance compared to the Omicron variant.
The main associated factors for death were fever, dyspnea, oxygen saturation below 95% on room air, age under one year, cardiac disease comorbidity, immunodeficiency, and infection during the predominance of B1_wild, Gamma, and Delta variants. Understanding the epidemiological profile and associated factors for mortality in this population is essential to inform effective prevention and control measures and guide optimal clinical management.

PMID:
42968027
Bibliographic data and abstract were imported from PubMed on 20 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement